Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
Clinical trial NCT05771584 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05771584
- Sponsor
- Aston Sci. Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-04
- Primary completion
- 2027-02-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.